In Other News

• Biodesign and Thermo Fisher to Rapidly Assess Absorbed Radiation Dose

• Memorial Sloan Kettering Cancer Center Partners with Quest Diagnostics

• Roche Acquires Genia Technologies, Strengthens Next Generation Sequencing Pipeline

• Partnership with Lilly Expands Qiagen’s Personalized Healthcare Pipeline

• Uptake of Next-Generation Sequencing in Europe Driven Largely by Personalized Medicine Developments

• Microfluidic Point-of-Care Diagnostics Now a Must-Have

• American Genomics Company Enters the Indian Cancer Diagnostics Sector

• Response Genetics Expands Distribution of ResponseDX Testing into Mexico

• Distribution Agreement Signed for Assistant Digital Cell Imaging System

• BioConference Live to Welcome AACC 2014 President

• Digital Pathology Market to Grow Exponentially in China

• EKF Diagnostics Acquires Selah Genomics and DiaSpect Medical

• Infectious Disease Diagnostics Redefined by Emerging Technologies

• Response Genetics Enters Next Generation Sequencing with Lung Cancer Panel from Knight Cancer Institute

• Roche and Hitachi Renew Alliance in Diagnostics

• Stago's Headquarters Move to New Building

• Bio-Rad Acquires GnuBIO and Fast Integrated DNA Sequencing Platform

• Beckman Coulter and hc1.com Enter Strategic Partnership for Innovative Healthcare Cloud System

• Roche Acquires IQuum, Strengthens Diagnostics Offerings with Unique System

• More Entrants into Veterinary Diagnostics Expected

• Ventana Signs Companion Diagnostic Agreement for Genmab Antibody-Drug Conjugate

• ACLA Supports Government Passage of Provisions for Clinical Laboratory Fee Schedule

• New Health Hubs Offer Guidance and Risk-Factor Blood Testing Services